FDA grants full approval to Covid-19 vaccine developed by Pfizer, BioNTech
(By Helen Branswell and Andrew Joseph for STAT) The Food and Drug Administration on Monday granted full approval to the
Read More
FDA
‘We Sent a Terrible Message’: Scientists Say Biden Jumped the Gun With Vaccine Booster Plan
(By Rachana Pradhan for Kaiser Health News) The Biden administration’s plans to make covid-19 booster shots available next month has
Read MoreReserve purple wristbands to identify DNR status, FDA tells device makers
(By Erica Carbajal for Becker’s Hospital Review) The FDA is asking medical device manufacturers to avoid giving purple wristbands to
Read MoreRush to Boosters Sparks Confusion, Differing Recommendations
(By Sarah Jane Tribble for Kaiser Health News) When the Food and Drug Administration announced last week that a third
Read MoreFacing Headwinds on New Alzheimer’s Drug, Biogen Launches Controversial Campaign
(By Julie Appleby for Kaiser Health News) Do you sometimes lose your train of thought or feel a bit more
Read MoreAnalysis: Necessary or Not, Covid Booster Shots Are Probably on the Horizon
(By Elisabeth Rosenthal for Kaiser Health News) The drugmaker Pfizer recently announced that vaccinated people are likely to need a
Read MoreDying Patients With Rare Diseases Struggle to Get Experimental Therapies
(By Christina Bennett for Kaiser Health News) At 15, Autumn Fuernisen is dying. She was diagnosed at age 11 with
Read MoreWhy We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
(By Elisabeth Rosenthal for Kaiser Health News) The Food and Drug Administration’s approval in June of a drug purporting to
Read MoreThe Ensuring Patient Access to Critical Breakthrough Products Act
The bipartisan bill, The Ensuring Patient Access to Critical Breakthrough Products Act, would require Medicare to cover all breakthrough devices
Read MoreQ&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read More